We are live on ! Find out more
VTAK icon

Catheter Precision
VTAK

12 hedge funds and large institutions have $103K invested in Catheter Precision in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

33% more funds holding

Funds holding: 9 → 12 (+3)

0.22% more ownership

Funds ownership: 4.1% → 4.32% (+0.22%)

18% less capital invested

Capital invested by funds: $125K → $103K (-$22.2K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
12
Holders Change
+3
Holders Change %
+33.33%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$80.8K
2
VF
Virtu Financial
New York
+$22.8K
3
Jane Street
Jane Street
New York
+$19.3K
4
HF
HRT Financial
New York
+$19.1K
5
TRCT
Tower Research Capital (TRC)
New York
+$873

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$36.6K
2
Citadel Advisors
Citadel Advisors
Florida
-$23.4K
3
UBS Group
UBS Group
Switzerland
-$1.32K
4
Bank of America
Bank of America
North Carolina
-$544

VTAK Hedge Fund Activity: Q1 2026 in Review

12 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q1 2026, worth a combined $103K — down 18% from $125K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new VTAK positions and 2 closed out — a net gain of 4 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $80.8K. The largest seller was Millennium Management, cutting an estimated $36.6K.

  • 12 institutional investors held Catheter Precision (VTAK) as of Q1 2026, up from 9 in Q4 2025.
  • Funds reported $103K of Catheter Precision stock for Q1 2026, down 18% quarter-over-quarter.
  • 6 funds opened new Catheter Precision positions in Q1 2026 and 2 closed out, a net change of +4 holders.
  • The largest Catheter Precision buyer in Q1 2026 was Geode Capital Management, an estimated $80.8K added.
  • The largest Catheter Precision seller in Q1 2026 was Millennium Management, an estimated $36.6K sold.

Based on aggregated 13F filings for Q1 2026.